Venetoclax, lenalidomide + rituximab: a chemotherapy-free regimen for previously untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:50 1 year ago 246 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in MCL & the importance of chemotherapy-free regimens VJHemOnc – Video Journal of Hematology & HemOnc 3:42 1 year ago 269 Скачать Далее
Addition of venetoclax to lenalidomide and rituximab in patients with untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 133 Скачать Далее
Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 214 Скачать Далее
The RELEVANCE study: lenalidomide plus rituximab vs. rituximab-chemotherapy in the treatment of FL VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 182 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
Acalabrutinib and rituximab as first-line therapy for older patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 447 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in the treatment of MCL VJHemOnc – Video Journal of Hematology & HemOnc 0:26 2 years ago 128 Скачать Далее
Standard of care treatment approaches in MCL and the role of chemotherapy-free regimens VJHemOnc – Video Journal of Hematology & HemOnc 2:44 1 year ago 74 Скачать Далее
Chemotherapy-free treatment for MCL: success from the WINDOW-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 445 Скачать Далее
Does upfront treatment with venetoclax, lenalidomide, and rituximab enhance tumor responses in MCL? Lymphoma Hub 2:35 3 years ago 109 Скачать Далее
Venetoclax and R2 in mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 5:50 3 years ago 412 Скачать Далее
TrAVeRse: acalabrutinib + venetoclax and rituximab for treatment-naïve MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:12 6 months ago 141 Скачать Далее
Phase II trial of acalabrutinib, lenalidomide and rituximab in patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 5:12 1 year ago 128 Скачать Далее
Real-world data on previously untreated MCL in the US and the SHINE study VJHemOnc – Video Journal of Hematology & HemOnc 3:47 3 years ago 257 Скачать Далее
PHILEMON trial: ibrutinib, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 3 years ago 79 Скачать Далее
Lymphoma Hub Satellite Symposium 2019 | MCL - chemotherapy-free regimens - Simon Rule Lymphoma Hub 9:44 4 years ago 195 Скачать Далее
Advancements in MCL treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:03 2 years ago 153 Скачать Далее
Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab in Untreated Mantle Cell Lymphoma Patients WCMNYP JCTO 2:17 4 years ago 136 Скачать Далее
